These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 17016521)
21. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. Pinkas-Kramarski R; Soussan L; Waterman H; Levkowitz G; Alroy I; Klapper L; Lavi S; Seger R; Ratzkin BJ; Sela M; Yarden Y EMBO J; 1996 May; 15(10):2452-67. PubMed ID: 8665853 [TBL] [Abstract][Full Text] [Related]
22. Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells. Talukder AH; Wang RA; Kumar R Oncogene; 2002 Jun; 21(27):4289-300. PubMed ID: 12082616 [TBL] [Abstract][Full Text] [Related]
23. The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression. Xu F; Yu Y; Le XF; Boyer C; Mills GB; Bast RC Clin Cancer Res; 1999 Nov; 5(11):3653-60. PubMed ID: 10589783 [TBL] [Abstract][Full Text] [Related]
24. Biology of HER2 and its importance in breast cancer. Yarden Y Oncology; 2001; 61 Suppl 2():1-13. PubMed ID: 11694782 [TBL] [Abstract][Full Text] [Related]
25. Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity. Nowak F; Jacquemin-Sablon A; Pierre J Exp Cell Res; 1997 Mar; 231(2):251-9. PubMed ID: 9087165 [TBL] [Abstract][Full Text] [Related]
26. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin. Berquin IM; Dziubinski ML; Nolan GP; Ethier SP Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130 [TBL] [Abstract][Full Text] [Related]
27. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides. Motoyama AB; Hynes NE; Lane HA Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928 [TBL] [Abstract][Full Text] [Related]
31. Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells. Kim J; Lee J; Kim C; Choi J; Kim A Tumour Biol; 2016 May; 37(5):5811-9. PubMed ID: 26581908 [TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020 [TBL] [Abstract][Full Text] [Related]
33. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Badache A; Hynes NE Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191 [TBL] [Abstract][Full Text] [Related]
34. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line. Frohnert PW; Stonecypher MS; Carroll SL Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503 [TBL] [Abstract][Full Text] [Related]
35. Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation. Rivas MA; Tkach M; Beguelin W; Proietti CJ; Rosemblit C; Charreau EH; Elizalde PV; Schillaci R Breast Cancer Res Treat; 2010 Jul; 122(1):111-24. PubMed ID: 19760502 [TBL] [Abstract][Full Text] [Related]
36. Estrogen-independent activation of erbBs signaling and estrogen receptor alpha in the mouse vagina exposed neonatally to diethylstilbestrol. Miyagawa S; Katsu Y; Watanabe H; Iguchi T Oncogene; 2004 Jan; 23(2):340-9. PubMed ID: 14647453 [TBL] [Abstract][Full Text] [Related]